Literature DB >> 15111677

Symptomatic distal sensory polyneuropathy in HIV after age 50.

M R Watters1, P W Poff, B T Shiramizu, P S Holck, K M S Fast, C M Shikuma, V G Valcour.   

Abstract

OBJECTIVE: To determine if aging changes the frequency, severity, or manifestations of symptomatic distal sensory polyneuropathy (SxDSPN) in patients with HIV-1.
METHODS: Prospective observations of 70 older (age < or = 50) and 56 younger (age 20 to 40) patients with HIV, and a control group of 48 older non-HIV patients, were conducted utilizing neurologic examination, neuropsychological testing, lumbar puncture, laboratory, and medical history.
RESULTS: The frequency of SxDSPN among older HIV patients was 50.4%, compared to 19.6% among younger HIV patients (p < 0.001). SxDSPN among control patients occurred in 4.2%, similar to the general population. Older compared to younger HIV patients demonstrated more severe symptoms (p = 0.02) and greater deficits for vibration (p < 0.01). Increasing numbers of neuropathic comorbidities among older compared to younger HIV patients were associated with increasing severity of deficits to pinprick (p = 0.003). Dementia and SxDSPN coexisted in 36% of the older HIV patients and in none of the younger HIV patients (p = 0.021). Older HIV patients with nadir CD4 < or =200 cells/mL were 4.23 times as likely to have SxDSPN than older patients with nadir CD4 >200 cells/mL (p = 0.007). Vibratory deficits excessive to pinprick deficits predicted SxDSPN among older (OR 2.83) but not younger seropositive patients (p = 0.036).
CONCLUSIONS: Age > or = 50 increases the frequency of SxDSPN, and is associated with both vibratory loss as the predominant sensory deficit and increased severity of pinprick loss among symptomatic patients with neuropathic comorbidities. SxDSPN is associated with both dementia and low nadir CD4 in HIV-positive patients aged 50 and greater.

Entities:  

Mesh:

Year:  2004        PMID: 15111677     DOI: 10.1212/01.wnl.0000120622.91018.ea

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

Review 1.  HIV-associated neuropathic pain: epidemiology, pathophysiology and management.

Authors:  Susama Verma; Lydia Estanislao; David Simpson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Incident neuropathy in HIV-infected patients on HAART.

Authors:  Beau K Nakamoto; Aaron McMurtray; James Davis; Victor Valcour; Michael R Watters; Bruce Shiramizu; Dominic C Chow; Kalpana Kallianpur; Cecilia M Shikuma
Journal:  AIDS Res Hum Retroviruses       Date:  2010-07       Impact factor: 2.205

Review 3.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

4.  Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort.

Authors:  Victor Valcour; Priscilla Yee; Andrew E Williams; Bruce Shiramizu; Michael Watters; Ola Selnes; Robert Paul; Cecilia Shikuma; Ned Sacktor
Journal:  J Neurovirol       Date:  2006-10       Impact factor: 2.643

5.  Mindfulness-based stress reduction for HIV-associated neurocognitive disorder: Rationale and protocol for a randomized controlled trial in older adults.

Authors:  Elizabeth L Addington; Shireen Javandel; Victor De Gruttola; Robert Paul; Benedetta Milanini; Beau M Ances; Judith T Moskowitz; Victor Valcour
Journal:  Contemp Clin Trials       Date:  2020-09-15       Impact factor: 2.226

Review 6.  Accelerated aging and human immunodeficiency virus infection: emerging challenges of growing older in the era of successful antiretroviral therapy.

Authors:  Ramona Bhatia; Patrick Ryscavage; Babafemi Taiwo
Journal:  J Neurovirol       Date:  2011-12-29       Impact factor: 2.643

7.  Increased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya.

Authors:  Christine J McGrath; Julia Njoroge; Grace C John-Stewart; Pamela K Kohler; Sarah F Benki-Nugent; Joan W Thiga; Anthony Etyang; Michael H Chung
Journal:  J Neurovirol       Date:  2012-04-17       Impact factor: 2.643

8.  Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy.

Authors:  Victor Valcour; Michael R Watters; Andrew E Williams; Ned Sacktor; Aaron McMurtray; Cecilia Shikuma
Journal:  J Neurovirol       Date:  2008-11-12       Impact factor: 2.643

9.  HIV Associated Sensory Neuropathy.

Authors:  Amruth G; Praveen-Kumar S; Nataraju B; Nagaraja Bs
Journal:  J Clin Diagn Res       Date:  2014-07-20

10.  Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation.

Authors:  Samantha X Y Wang; Emily L Ho; Marie Grill; Evelyn Lee; Julia Peterson; Kevin Robertson; Dietmar Fuchs; Elizabeth Sinclair; Richard W Price; Serena Spudich
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.